Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | GBA2 | Q9HCG7 | 14/20 | 0.44 |
| ▸ | GBA1 | P04062 | 9/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1072083 | 0.98 | MEN1 (0.54) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL29013371 | 0.91 | TSHR (0.56) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL8611137 | 0.89 | HTT (0.64) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL8482624 | 0.89 | HTT (0.64) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL1115457 | 0.89 | HTT (0.64) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL8483594 | 0.89 | HTT (0.64) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL8478995 | 0.89 | HTT (0.64) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL4307710 | 0.89 | HTT (0.64) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL8481402 | 0.89 | HTT (0.64) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL18954849 | 0.89 | HTT (0.64) | MEN1THRBHTTKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240138407-A1 | ANTIMICROBIAL ENHANCEMENT OF CATIONIC ACTIVE SKIN ANTISEPTICS | ECOLAB USA INC. | 2024-05-02 | — | — | US | disclosed |
| US-11930819-B2 | Antimicrobial compositions with enhanced efficacy | ECOLAB USA INC. (US) | 2024-03-19 | — | — | US | disclosed |
| US-11889832-B2 | Antimicrobial enhancement of cationic active skin antiseptics | ECOLAB USA INC. (US) | 2024-02-06 | — | — | US | disclosed |
| EP-3968770-A1 | ANTIMICROBIAL ENHANCEMENT OF CATIONIC ACTIVE SKIN ANTISEPTICS | Ecolab USA Inc. (US) | 2022-03-23 | — | — | EP | disclosed |
| US-11116220-B2 | Antimicrobial compositions with enhanced efficacy | ECOLAB USA INC. (US) | 2021-09-14 | — | — | US | disclosed |
| US-20210235700-A1 | ANTIMICROBIAL COMPOSITIONS WITH ENHANCED EFFICACY | ECOLAB USA INC. | 2021-08-05 | — | — | US | disclosed |
| WO-2020236718-A1 | ANTIMICROBIAL ENHANCEMENT OF CATIONIC ACTIVE SKIN ANTISEPTICS | ECOLAB USA INC. (US) | 2020-11-26 | — | — | WO | disclosed |
| US-20200359622-A1 | ANTIMICROBIAL ENHANCEMENT OF CATIONIC ACTIVE SKIN ANTISEPTICS | ECOLAB USA INC. | 2020-11-19 | — | — | US | disclosed |
| US-20190191704-A1 | ANTIMICROBIAL COMPOSITIONS WITH ENHANCED EFFICACY | ECOLAB USA INC. | 2019-06-27 | — | — | US | disclosed |
| WO-2019070920-A1 | COMPOSITIONS, METHODS AND USES FOR IMPROVING A SKIN OR HAIR REGION | Collidion, Inc. (US) | 2019-04-11 | — | — | WO | disclosed |
| US-20190099336-A1 | Compositions, Methods and Uses for Improving a Skin or Hair Region | Collidion, Inc. (US) | 2019-04-04 | — | — | US | disclosed |
| CN-106714772-A | Sulfate-free personal care compositions and methods | 海名斯精细化工公司 | 2017-05-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11930819-B2 | Antimicrobial compositions with enhanced efficacy | MGAM, GALE, GMDS | MEN1 3881/4885THRB 4329/4885HTT 2263/4885 |
| US-20190191704-A1 | ANTIMICROBIAL COMPOSITIONS WITH ENHANCED EFFICACY | MGAM, GALE, GMDS | MEN1 3881/4885THRB 4329/4885HTT 2263/4885 |
| US-20190099336-A1 | Compositions, Methods and Uses for Improving a Skin or Hair Region | CUTA, SCLY, SHH | MEN1 2442/4885THRB 2853/4885HTT 449/4885 |
| US-20210235700-A1 | ANTIMICROBIAL COMPOSITIONS WITH ENHANCED EFFICACY | MGAM, GALE, GMDS | MEN1 3881/4885THRB 4329/4885HTT 2263/4885 |
| US-11889832-B2 | Antimicrobial enhancement of cationic active skin antiseptics | CUTA, ARG1, LPO | MEN1 4374/4885THRB 4852/4885HTT 3200/4885 |
| US-20200359622-A1 | ANTIMICROBIAL ENHANCEMENT OF CATIONIC ACTIVE SKIN ANTISEPTICS | CUTA, ARG1, LPO | MEN1 4374/4885THRB 4852/4885HTT 3200/4885 |
| US-20240138407-A1 | ANTIMICROBIAL ENHANCEMENT OF CATIONIC ACTIVE SKIN ANTISEPTICS | CUTA, ARG1, LPO | MEN1 4374/4885THRB 4852/4885HTT 3200/4885 |
| US-11116220-B2 | Antimicrobial compositions with enhanced efficacy | MGAM, GALE, GMDS | MEN1 3881/4885THRB 4329/4885HTT 2263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.